Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus-Reference-Cited by-同舟云学术

Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus

Published:2013-09 Issue:40 Volume:31 Page:4305-4313
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Smith Gale E.,Flyer David C.,Raghunandan Ramadevi,Liu Ye,Wei Ziping,Wu Yingyun,Kpamegan Eloi,Courbron Denise,Fries Louis F.,Glenn Gregory M.

Funder

Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, Department of Health and Human Services

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference21 articles.

1. Schnirring L. Federal officials weigh H7N9 vaccine options. http://www.cidrap.umn.edu/cidrap/content/influenza/avianflu/news/jun1113vaccine.html; 2013 [accessed 13.06.13].

2. Major challenges in providing an effective and timely pandemic vaccine for influenza A(H7N9);Osterholm;JAMA,2013

3. Pandemic influenza viruses – hoping for the road not taken;Morens;N Engl J Med,2013

4. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance;Hu;Lancet,2013

5. Synthetic generation of influenza vaccine viruses for rapid response to pandemics;Dormitzer;Sci Transl Med,2013

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanovaccines for cancer immunotherapy: Current knowledge and future perspectives;Chinese Chemical Letters;2022-12

2. Influenza A(H7N9) Pandemic Preparedness: Assessment of the Breadth of Heterologous Antibody Responses to Emerging Viruses from Multiple Pre-Pandemic Vaccines and Population Immunity;Vaccines;2022-11-01

3. Induction of immunogenic response in Balb/c mice by virus-like particles designed using the influenza neuraminidase, hemagglutinin and matrix proteins;Acta virologica;2022

4. Solutions against emerging infectious and noninfectious human diseases through the application of baculovirus technologies;Applied Microbiology and Biotechnology;2021-10-07

5. Downstream processing for influenza vaccines and candidates: An update;Biotechnology and Bioengineering;2021-05-11